Muhammad Mustafa Qureshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Mustafa Qureshi has a total of 366 co-authors. Here are the top co-authors by number of shared publications:
- Mohamad Abdalkader
Boston Medical Center
13 shared publications - Thanh N. Nguyen
Boston Medical Center
13 shared publications - Piers Klein
Department of Radiology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA
12 shared publications - Raul Gomes Nogueira
Department of Neurology and Neurosurgery, UPMC Stroke Institute, University of Pittsburgh School of Medicine, PA
12 shared publications - Daniel Strbian
Department of Neurology, Helsinki University Hospital and University of Helsinki , Helsinki
11 shared publications - Davide Strambo
Stroke Center, Service of Neurology, Department of Clinical Neurosciences (D. Strambo, C.M.T.), University Hospital of Lausanne and University of Lausanne, Switzerland
11 shared publications
Latest Publications
- 11 October 2026
- Published by Wiley in Head & Neck
CyberKnife Stereotactic Body Radiotherapy for Reirradiation of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Outcomes and Prognostic Factors
Background: Stereotactic body radiotherapy (SBRT) is used for reirradiation in recurrent or metastatic head and neck squamous cell carcinoma (RM‐HNSCC), but prognostic factors remain unclear. Methods: We retrospectively analyzed 36 RM‐HNSCC patients treated with CyberKnife‐SBRT (2009–2022). Endpoints: local control (LC) and overall survival (OS), estimated using Kaplan–Meier and Cox regression. Results: Median follow‐up was 8.5 months, median OS was 9.6 months, with 1‐ and 2‐year OS rates of 43.5% and 34.2%. One‐ and 2‐year LC rates were 55.1% and 34.5%, with median time‐to‐recurrence of 14.1 months. On multivariable analysis, smoking > 30 pack‐years predicted worse LC (HR 5.68; 95% CI, 1.42–22.70; p = 0.014), while former/never smoking predicted improved OS (HR 0.26; 95% CI, 0.08–0.82; p = 0.022). Gross tumor volume > 37.0 cm 3 predicted worse LC (log‐rank p = 0.044) and OS ( p = 0.003) on univariate analysis. Conclusions: Smoking history independently predicted LC and OS; larger tumor volume was associated with worse outcomes and may inform patient selection for SBRT reirradiation.
- 11 October 2026
- Published by Wiley in Head & Neck
CyberKnife Stereotactic Body Radiotherapy for Reirradiation of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Outcomes and Prognostic Factors
Background: Stereotactic body radiotherapy (SBRT) is used for reirradiation in recurrent or metastatic head and neck squamous cell carcinoma (RM‐HNSCC), but prognostic factors remain unclear. Methods: We retrospectively analyzed 36 RM‐HNSCC patients treated with CyberKnife‐SBRT (2009–2022). Endpoints: local control (LC) and overall survival (OS), estimated using Kaplan–Meier and Cox regression. Results: Median follow‐up was 8.5 months, median OS was 9.6 months, with 1‐ and 2‐year OS rates of 43.5% and 34.2%. One‐ and 2‐year LC rates were 55.1% and 34.5%, with median time‐to‐recurrence of 14.1 months. On multivariable analysis, smoking > 30 pack‐years predicted worse LC (HR 5.68; 95% CI, 1.42–22.70; p = 0.014), while former/never smoking predicted improved OS (HR 0.26; 95% CI, 0.08–0.82; p = 0.022). Gross tumor volume > 37.0 cm 3 predicted worse LC (log‐rank p = 0.044) and OS ( p = 0.003) on univariate analysis. Conclusions: Smoking history independently predicted LC and OS; larger tumor volume was associated with worse outcomes and may inform patient selection for SBRT reirradiation.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2661-2676
Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke
BACKGROUND: The optimal management of isolated posterior cerebral artery occlusion (iPCAO) remains unclear. We investigated whether baseline perfusion imaging parameters are associated with clinical outcomes and whether they modify the association between endovascular therapy (EVT) and outcomes in iPCAO. METHODS: This prespecified secondary analysis of the international, multicenter, observational PLATO (Posterior Cerebral Artery Occlusion) registry (35 centers, 10 countries, 2015–2025) included consecutive adults with unilateral iPCAO and baseline perfusion imaging (computed tomography or magnetic resonance imaging) with reconstructed parameters. The primary end point was an excellent 90-day outcome (modified Rankin Scale score, 0–1). Perfusion parameters included hypoperfusion volume, infarct core volume, and mismatch ratio. The primary analysis used multivariable mixed-effects regression models (center as random effect) to assess associations between perfusion parameters and outcomes, adjusting for age, sex, treatment year, prestroke modified Rankin Scale score, baseline National Institutes of Health Stroke Scale score, diabetes, stroke cause, posterior circulation Acute Stroke Prognosis Early Computed Tomography Score, occlusion site, intravenous thrombolysis, and onset-to-door time. To test whether the association between EVT and outcomes varies according to baseline perfusion parameters, we evaluated treatment-by-perfusion interactions by including interaction terms (treatment×perfusion parameter) in inverse probability of treatment weighting–adjusted models, with results expressed as ratios of odds ratios (ORs). RESULTS: Of 1811 patients with iPCAO, 443 met inclusion criteria (median age, 74 years; 41.8% female). Larger hypoperfusion volume was associated with lower odds of excellent outcome (adjusted OR, 0.72 [95% CI, 0.58–0.89] per 1-unit increase in natural logarithm–transformed volume). No interaction between perfusion parameters and EVT was observed for the primary outcome. However, increasing core volume was associated with a progressively less favorable modified Rankin Scale score shift (ratio of OR, 0.66 [95% CI, 0.48–0.90]; P interaction =0.009) and higher mortality (ratio of OR, 1.82 [95% CI, 1.10–3.03]; P interaction =0.021) with EVT compared with medical management. Increasing hypoperfusion volume was associated with a higher risk of symptomatic intracranial hemorrhage with EVT (ratio of OR, 10.15 [95% CI, 1.06–96.93]; P interaction =0.044). CONCLUSIONS: In iPCAO, perfusion imaging provides independent prognostic information but does not identify patients with potential benefit from EVT and may instead indicate those at higher procedural risk. REGISTRATION: URL: https://osf.io/62mwt ; Unique identifier: NCT05291637.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2661-2676
Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke
BACKGROUND: The optimal management of isolated posterior cerebral artery occlusion (iPCAO) remains unclear. We investigated whether baseline perfusion imaging parameters are associated with clinical outcomes and whether they modify the association between endovascular therapy (EVT) and outcomes in iPCAO. METHODS: This prespecified secondary analysis of the international, multicenter, observational PLATO (Posterior Cerebral Artery Occlusion) registry (35 centers, 10 countries, 2015–2025) included consecutive adults with unilateral iPCAO and baseline perfusion imaging (computed tomography or magnetic resonance imaging) with reconstructed parameters. The primary end point was an excellent 90-day outcome (modified Rankin Scale score, 0–1). Perfusion parameters included hypoperfusion volume, infarct core volume, and mismatch ratio. The primary analysis used multivariable mixed-effects regression models (center as random effect) to assess associations between perfusion parameters and outcomes, adjusting for age, sex, treatment year, prestroke modified Rankin Scale score, baseline National Institutes of Health Stroke Scale score, diabetes, stroke cause, posterior circulation Acute Stroke Prognosis Early Computed Tomography Score, occlusion site, intravenous thrombolysis, and onset-to-door time. To test whether the association between EVT and outcomes varies according to baseline perfusion parameters, we evaluated treatment-by-perfusion interactions by including interaction terms (treatment×perfusion parameter) in inverse probability of treatment weighting–adjusted models, with results expressed as ratios of odds ratios (ORs). RESULTS: Of 1811 patients with iPCAO, 443 met inclusion criteria (median age, 74 years; 41.8% female). Larger hypoperfusion volume was associated with lower odds of excellent outcome (adjusted OR, 0.72 [95% CI, 0.58–0.89] per 1-unit increase in natural logarithm–transformed volume). No interaction between perfusion parameters and EVT was observed for the primary outcome. However, increasing core volume was associated with a progressively less favorable modified Rankin Scale score shift (ratio of OR, 0.66 [95% CI, 0.48–0.90]; P interaction =0.009) and higher mortality (ratio of OR, 1.82 [95% CI, 1.10–3.03]; P interaction =0.021) with EVT compared with medical management. Increasing hypoperfusion volume was associated with a higher risk of symptomatic intracranial hemorrhage with EVT (ratio of OR, 10.15 [95% CI, 1.06–96.93]; P interaction =0.044). CONCLUSIONS: In iPCAO, perfusion imaging provides independent prognostic information but does not identify patients with potential benefit from EVT and may instead indicate those at higher procedural risk. REGISTRATION: URL: https://osf.io/62mwt ; Unique identifier: NCT05291637.
- Open Access
- 1 February 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 362-370
Outcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window
BACKGROUND: It remains unclear whether outcomes of patients treated with endovascular thrombectomy with large-vessel occlusion and unwitnessed onset of stroke differ from those with witnessed onset in the extended time window. METHODS: We enrolled patients with anterior circulation large-vessel occlusion (internal carotid artery, M1, or M2 segment of the middle cerebral artery) undergoing endovascular thrombectomy within 6 to 24 hours from the time last seen well, from 2014 to 2022, at 66 sites in Europe, North America, and Asia. Patients with a prestroke modified Rankin Scale score of >3 or age P =0.022). Mortality was 21.6% among unwitnessed and 22.0% among witnessed ( P =0.847), and symptomatic intracranial hemorrhage rates were 6.6% and 5.8%, respectively ( P =0.623). The primary outcome (modified Rankin Scale shift) showed no difference comparing unwitnessed to witnessed patients (odds ratio, 1.35 [95% CI, 0.82–2.20]; P =0.235) in the inverse probability of treatment weighting. Unwitnessed patients were more likely to achieve functional independence or return of Rankin (1.53 [1.01–2.33]; P =0.045). Other secondary outcomes did not differ between the witnessed and unwitnessed patients. CONCLUSIONS: In the extended time window, unwitnessed patients with large-vessel occlusion undergoing endovascular thrombectomy have at least the same likelihood of favorable outcomes as witnessed patients. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04096248.
- 1 February 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 362-370
Open AccessOutcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window
BACKGROUND: It remains unclear whether outcomes of patients treated with endovascular thrombectomy with large-vessel occlusion and unwitnessed onset of stroke differ from those with witnessed onset in the extended time window. METHODS: We enrolled patients with anterior circulation large-vessel occlusion (internal carotid artery, M1, or M2 segment of the middle cerebral artery) undergoing endovascular thrombectomy within 6 to 24 hours from the time last seen well, from 2014 to 2022, at 66 sites in Europe, North America, and Asia. Patients with a prestroke modified Rankin Scale score of >3 or age P =0.022). Mortality was 21.6% among unwitnessed and 22.0% among witnessed ( P =0.847), and symptomatic intracranial hemorrhage rates were 6.6% and 5.8%, respectively ( P =0.623). The primary outcome (modified Rankin Scale shift) showed no difference comparing unwitnessed to witnessed patients (odds ratio, 1.35 [95% CI, 0.82–2.20]; P =0.235) in the inverse probability of treatment weighting. Unwitnessed patients were more likely to achieve functional independence or return of Rankin (1.53 [1.01–2.33]; P =0.045). Other secondary outcomes did not differ between the witnessed and unwitnessed patients. CONCLUSIONS: In the extended time window, unwitnessed patients with large-vessel occlusion undergoing endovascular thrombectomy have at least the same likelihood of favorable outcomes as witnessed patients. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04096248.
- 22 September 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 214, 111161
The climate and health impact of U.S. radiation therapy: estimating greenhouse gas emissions, DALYs, and potential of hypofractionation
- 22 September 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 214, 111161
The climate and health impact of U.S. radiation therapy: estimating greenhouse gas emissions, DALYs, and potential of hypofractionation
- 12 August 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (3) , e213911
Noncontrast CT vs CT Perfusion Imaging in Patients With Basilar Artery Occlusion
Acute CT perfusion (CTP) or MRI is not widely available or routinely performed across many stroke centers. We aimed to evaluate whether patients with acute basilar artery occlusion (BAO) who are selected by noncontrast CT (NCCT) for endovascular therapy (EVT) have similar outcomes compared with patients who are selected by CTP. This was a post hoc analysis of individual patient-level data from the ATTENTION and ATTENTION IA trials. Patients with BAO presenting within 24 hours of estimated onset and selected for EVT by NCCT were compared with those selected by CTP. The primary outcome was the 90-day modified Rankin Scale (mRS) score of 0-3. We used inverse probability of treatment weighting (IPTW) to account for confounders. Of 550 patients with BAO, 406 met eligibility criteria, of whom 274 (67.5%) were selected for EVT by NCCT and 132 (32.5%) were selected by CTP. The median (interquartile range, [IQR]) age was 67 (57-74) years, 70.7% were male, the median (IQR) baseline NIH Stroke Scale score was 23 (14-35), and the median (IQR) posterior circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS) was 9 (8-10). The primary outcome was similar in both NCCT and CTP groups (mRS scores 0-3: 48.5% vs 45.5%, p = 0.56, respectively). Functional independence at 90 days (mRS scores 0-2: 37.2% vs 33.3%, p = 0.44, respectively), symptomatic intracranial hemorrhage (4.5% vs 7.5%, p = 0.29), and 90-day mortality (32.1% vs 34.9%, p = 0.83) were similar in both groups, respectively. In IPTW analysis, there was no difference in mRS scores 0-3 at 90 days (odds ratio 0.88 [95% CI 0.58-1.32], p = 0.53). In patients with BAO treated with EVT up to the 24-hour time window, there was no difference in clinical or safety outcomes in patients selected by NCCT compared with CT perfusion. This study provides Class IV evidence that in patients with BAO, selection for EVT using NCCT yields similar clinical and safety outcomes compared with selection for EVT using CT perfusion. ATTENTION: ClinicalTrials.gov NCT04751708. ATTENTION IA: ClinicalTrials.gov NCT05684172.
- 12 August 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (3) , e213911
Noncontrast CT vs CT Perfusion Imaging in Patients With Basilar Artery Occlusion
Acute CT perfusion (CTP) or MRI is not widely available or routinely performed across many stroke centers. We aimed to evaluate whether patients with acute basilar artery occlusion (BAO) who are selected by noncontrast CT (NCCT) for endovascular therapy (EVT) have similar outcomes compared with patients who are selected by CTP. This was a post hoc analysis of individual patient-level data from the ATTENTION and ATTENTION IA trials. Patients with BAO presenting within 24 hours of estimated onset and selected for EVT by NCCT were compared with those selected by CTP. The primary outcome was the 90-day modified Rankin Scale (mRS) score of 0-3. We used inverse probability of treatment weighting (IPTW) to account for confounders. Of 550 patients with BAO, 406 met eligibility criteria, of whom 274 (67.5%) were selected for EVT by NCCT and 132 (32.5%) were selected by CTP. The median (interquartile range, [IQR]) age was 67 (57-74) years, 70.7% were male, the median (IQR) baseline NIH Stroke Scale score was 23 (14-35), and the median (IQR) posterior circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS) was 9 (8-10). The primary outcome was similar in both NCCT and CTP groups (mRS scores 0-3: 48.5% vs 45.5%, p = 0.56, respectively). Functional independence at 90 days (mRS scores 0-2: 37.2% vs 33.3%, p = 0.44, respectively), symptomatic intracranial hemorrhage (4.5% vs 7.5%, p = 0.29), and 90-day mortality (32.1% vs 34.9%, p = 0.83) were similar in both groups, respectively. In IPTW analysis, there was no difference in mRS scores 0-3 at 90 days (odds ratio 0.88 [95% CI 0.58-1.32], p = 0.53). In patients with BAO treated with EVT up to the 24-hour time window, there was no difference in clinical or safety outcomes in patients selected by NCCT compared with CT perfusion. This study provides Class IV evidence that in patients with BAO, selection for EVT using NCCT yields similar clinical and safety outcomes compared with selection for EVT using CT perfusion. ATTENTION: ClinicalTrials.gov NCT04751708. ATTENTION IA: ClinicalTrials.gov NCT05684172.
- 11 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (2) , 482-488
Outcome Prediction in Pediatric Traumatic Brain Injury Utilizing Social Determinants of Health and Machine Learning Methods
Considerable socioeconomic disparities exist among pediatric traumatic brain injury (TBI) patients. This study aims to analyze the effects of social determinants of health on head injury outcomes and to create a novel machine-learning algorithm (MLA) that incorporates socioeconomic factors to predict the likelihood of a positive or negative trauma-related finding on head computed tomography (CT). A cohort of blunt trauma patients under age 15 who presented to the largest safety net hospital in New England between January 2006 and December 2013 (n=211) was included in this study. Patient socioeconomic data such as race, language, household income, and insurance type were collected alongside other parameters like Injury Severity Score (ISS), age, sex, and mechanism of injury. Multivariable analysis was performed to identify significant factors in predicting a positive head CT outcome. The cohort was split into 80% training (168 samples) and 20% testing (43 samples) datasets using stratified sampling. Twenty-two multi-parametric MLAs were trained with 5-fold cross-validation and hyperparameter tuning via GridSearchCV, and top-performing models were evaluated on the test dataset. Significant factors associated with pediatric head CT outcome included ISS, age, and insurance type (p<0.05). The age of the subjects with a clinically relevant trauma-related head CT finding (median= 1.8 years) was significantly different from the age of patients without such findings (median= 9.1 years). These predictors were utilized to train the machine learning models. With ISS, the Fine Gaussian SVM achieved the highest test AUC (0.923), with accuracy=0.837, sensitivity=0.647, and specificity=0.962. The Coarse Tree yielded accuracy=0.837, AUC=0.837, sensitivity=0.824, and specificity=0.846. Without ISS, the Narrow Neural Network performed best with accuracy=0.837, AUC=0.857, sensitivity=0.765, and specificity=0.885. Key predictors of clinically relevant head CT findings in pediatric TBI include ISS, age, and social determinants of health, with children under 5 at higher risk. A novel Fine Gaussian SVM model outperformed other MLA, offering high accuracy in predicting outcomes. This tool shows promise for improving clinical decisions while minimizing radiation exposure in children. TBI = Traumatic Brain Injury; ISS = Injury Severity Score; MLA = Machine Learning Algorithm; CT = Computed Tomography; AUC = Area Under the Curve.
- 11 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (2) , 482-488
Outcome Prediction in Pediatric Traumatic Brain Injury Utilizing Social Determinants of Health and Machine Learning Methods
Considerable socioeconomic disparities exist among pediatric traumatic brain injury (TBI) patients. This study aims to analyze the effects of social determinants of health on head injury outcomes and to create a novel machine-learning algorithm (MLA) that incorporates socioeconomic factors to predict the likelihood of a positive or negative trauma-related finding on head computed tomography (CT). A cohort of blunt trauma patients under age 15 who presented to the largest safety net hospital in New England between January 2006 and December 2013 (n=211) was included in this study. Patient socioeconomic data such as race, language, household income, and insurance type were collected alongside other parameters like Injury Severity Score (ISS), age, sex, and mechanism of injury. Multivariable analysis was performed to identify significant factors in predicting a positive head CT outcome. The cohort was split into 80% training (168 samples) and 20% testing (43 samples) datasets using stratified sampling. Twenty-two multi-parametric MLAs were trained with 5-fold cross-validation and hyperparameter tuning via GridSearchCV, and top-performing models were evaluated on the test dataset. Significant factors associated with pediatric head CT outcome included ISS, age, and insurance type (p<0.05). The age of the subjects with a clinically relevant trauma-related head CT finding (median= 1.8 years) was significantly different from the age of patients without such findings (median= 9.1 years). These predictors were utilized to train the machine learning models. With ISS, the Fine Gaussian SVM achieved the highest test AUC (0.923), with accuracy=0.837, sensitivity=0.647, and specificity=0.962. The Coarse Tree yielded accuracy=0.837, AUC=0.837, sensitivity=0.824, and specificity=0.846. Without ISS, the Narrow Neural Network performed best with accuracy=0.837, AUC=0.857, sensitivity=0.765, and specificity=0.885. Key predictors of clinically relevant head CT findings in pediatric TBI include ISS, age, and social determinants of health, with children under 5 at higher risk. A novel Fine Gaussian SVM model outperformed other MLA, offering high accuracy in predicting outcomes. This tool shows promise for improving clinical decisions while minimizing radiation exposure in children. TBI = Traumatic Brain Injury; ISS = Injury Severity Score; MLA = Machine Learning Algorithm; CT = Computed Tomography; AUC = Area Under the Curve.
- 1 July 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (7) , 1671-1680
Endovascular Therapy for Late-Window M2-Segment Middle Cerebral Artery Occlusion: Analysis of the CLEAR Study
BACKGROUND: There is uncertainty about whether patients with M2 occlusion benefit from endovascular therapy (EVT) in the late (6–24-hour) time window. We evaluated the clinical outcomes of patients with M2 occlusion selected for EVT compared with those who received medical management (MM) in the late window. METHODS: This multinational cohort study was conducted at 66 sites across 10 countries (January 2014 to May 2022). We included consecutive patients with late-window stroke due to M2 occlusion, baseline National Institutes of Health Stroke Scale score of ≥5, and premorbid modified Rankin Scale score of ≤2 who received EVT or MM alone. The primary end point was 90-day ordinal shift in the modified Rankin Scale score. Safety end points were symptomatic intracranial hemorrhage and 90-day mortality. Differences in outcomes were determined using inverse probability of treatment weighting–adjusted logistic regression models. RESULTS: Among 5098 patients, 496 met inclusion criteria (median [interquartile range] age, 74 years [62–81 years]; baseline National Institutes of Health Stroke Scale score, 12 [8–17]), of whom 394 (79.4%) received EVT and 102 (20.6%) MM. In inverse probability of treatment weighting adjusted analyses, there was no favorable 90-day ordinal modified Rankin Scale shift (odds ratio, 1.39 [95% CI, 0.92–2.12]) and no difference of functional independence rates (modified Rankin Scale score of 0–2; odds ratio, 1.72 [95% CI, 0.93–3.15]) with EVT compared with MM. Moreover, symptomatic intracranial hemorrhage risk (odds ratio, 3.46 [95% CI, 0.50–23.92]) and 90-day mortality (odds ratio, 1.11 [95% CI, 0.66–1.87]) were not statistically different between treatment groups. CONCLUSIONS: In patients with M2 occlusion in the 6- to 24-hour time window, there was no difference in disability outcomes or symptomatic intracranial hemorrhage risk between patients treated with EVT compared with MM. Results of ongoing randomized trials will provide further insight. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04096248.
- 1 July 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (7) , 1671-1680
Endovascular Therapy for Late-Window M2-Segment Middle Cerebral Artery Occlusion: Analysis of the CLEAR Study
BACKGROUND: There is uncertainty about whether patients with M2 occlusion benefit from endovascular therapy (EVT) in the late (6–24-hour) time window. We evaluated the clinical outcomes of patients with M2 occlusion selected for EVT compared with those who received medical management (MM) in the late window. METHODS: This multinational cohort study was conducted at 66 sites across 10 countries (January 2014 to May 2022). We included consecutive patients with late-window stroke due to M2 occlusion, baseline National Institutes of Health Stroke Scale score of ≥5, and premorbid modified Rankin Scale score of ≤2 who received EVT or MM alone. The primary end point was 90-day ordinal shift in the modified Rankin Scale score. Safety end points were symptomatic intracranial hemorrhage and 90-day mortality. Differences in outcomes were determined using inverse probability of treatment weighting–adjusted logistic regression models. RESULTS: Among 5098 patients, 496 met inclusion criteria (median [interquartile range] age, 74 years [62–81 years]; baseline National Institutes of Health Stroke Scale score, 12 [8–17]), of whom 394 (79.4%) received EVT and 102 (20.6%) MM. In inverse probability of treatment weighting adjusted analyses, there was no favorable 90-day ordinal modified Rankin Scale shift (odds ratio, 1.39 [95% CI, 0.92–2.12]) and no difference of functional independence rates (modified Rankin Scale score of 0–2; odds ratio, 1.72 [95% CI, 0.93–3.15]) with EVT compared with MM. Moreover, symptomatic intracranial hemorrhage risk (odds ratio, 3.46 [95% CI, 0.50–23.92]) and 90-day mortality (odds ratio, 1.11 [95% CI, 0.66–1.87]) were not statistically different between treatment groups. CONCLUSIONS: In patients with M2 occlusion in the 6- to 24-hour time window, there was no difference in disability outcomes or symptomatic intracranial hemorrhage risk between patients treated with EVT compared with MM. Results of ongoing randomized trials will provide further insight. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04096248.
- 8 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (7) , e213442
Endovascular Therapy for Patients With Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
There is uncertainty about whether patients with an anterior circulation large vessel occlusion (LVO) and a low NIH Stroke Scale (NIHSS) score (≤5) benefit from endovascular therapy (EVT) in the late time window (6-24 hours). We compared the clinical outcomes of these patients receiving EVT with those receiving medical management (MM). The CT for Late Endovascular Reperfusion multinational cohort study was conducted at 66 sites across 10 countries from January 2014 to May 2022. This subanalysis included consecutive patients with late-window stroke due to an anterior circulation LVO, defined as occlusion of the internal carotid artery or proximal middle cerebral artery (M1/M2 segments), and a baseline NIHSS score ≤5 who received EVT or MM alone. The primary end point was a 90-day ordinal shift in the modified Rankin Scale (mRS) score. Secondary outcomes were 90-day excellent outcome (defined as mRS scores 0-1 or return to baseline mRS score in patients with a prestroke mRS score >1) and favorable outcome (defined as mRS scores 0-2 or return to baseline mRS score in patients with prestroke mRS score >2). Safety outcomes were symptomatic intracranial hemorrhage and 90-day mortality. We used ordinal and binary logistic regression models to test for outcome differences. Among 5,098 patients, 318 patients were included (median [interquartile range] age 67 [56-76] years; 149 [46.9%] were female; baseline NIHSS score was 4 [2-5]). A total of 202 patients (63.5%) received EVT and 116 MM (36.5%). There was no difference in favorable 90-day ordinal mRS score shift (adjusted common odds ratio [OR] 0.77, 95% CI 0.45-1.32), excellent outcome (adjusted OR 0.86, 95% CI 0.49-1.50), or favorable outcome (adjusted OR 0.72, 95% CI 0.35-1.50) in the EVT group compared with MM. Symptomatic intracranial hemorrhage risk (adjusted OR 3.40, 95% CI 0.84-13.73) and mortality at 90 days (adjusted OR 2.44, 95% CI 0.60-10.02) were not statistically different between treatment groups. In patients with an anterior LVO and low NIHSS score in the 6-24-hour time window, there was no statistical difference in disability outcomes or intracranial bleeding risk between patients treated with EVT compared with MM. The retrospective and observational design limits our findings. Ongoing randomized controlled trials will provide further insight. This study provides Class III evidence that in adult patients with anterior circulation LVO and low NIHSS score (≤5) presenting in the late time window (6-24 hours), EVT does not improve clinical outcome vs MM. This study was registered at clinicaltrials.gov under NCT04096248.
- 8 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (7) , e213442
Endovascular Therapy for Patients With Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
There is uncertainty about whether patients with an anterior circulation large vessel occlusion (LVO) and a low NIH Stroke Scale (NIHSS) score (≤5) benefit from endovascular therapy (EVT) in the late time window (6-24 hours). We compared the clinical outcomes of these patients receiving EVT with those receiving medical management (MM). The CT for Late Endovascular Reperfusion multinational cohort study was conducted at 66 sites across 10 countries from January 2014 to May 2022. This subanalysis included consecutive patients with late-window stroke due to an anterior circulation LVO, defined as occlusion of the internal carotid artery or proximal middle cerebral artery (M1/M2 segments), and a baseline NIHSS score ≤5 who received EVT or MM alone. The primary end point was a 90-day ordinal shift in the modified Rankin Scale (mRS) score. Secondary outcomes were 90-day excellent outcome (defined as mRS scores 0-1 or return to baseline mRS score in patients with a prestroke mRS score >1) and favorable outcome (defined as mRS scores 0-2 or return to baseline mRS score in patients with prestroke mRS score >2). Safety outcomes were symptomatic intracranial hemorrhage and 90-day mortality. We used ordinal and binary logistic regression models to test for outcome differences. Among 5,098 patients, 318 patients were included (median [interquartile range] age 67 [56-76] years; 149 [46.9%] were female; baseline NIHSS score was 4 [2-5]). A total of 202 patients (63.5%) received EVT and 116 MM (36.5%). There was no difference in favorable 90-day ordinal mRS score shift (adjusted common odds ratio [OR] 0.77, 95% CI 0.45-1.32), excellent outcome (adjusted OR 0.86, 95% CI 0.49-1.50), or favorable outcome (adjusted OR 0.72, 95% CI 0.35-1.50) in the EVT group compared with MM. Symptomatic intracranial hemorrhage risk (adjusted OR 3.40, 95% CI 0.84-13.73) and mortality at 90 days (adjusted OR 2.44, 95% CI 0.60-10.02) were not statistically different between treatment groups. In patients with an anterior LVO and low NIHSS score in the 6-24-hour time window, there was no statistical difference in disability outcomes or intracranial bleeding risk between patients treated with EVT compared with MM. The retrospective and observational design limits our findings. Ongoing randomized controlled trials will provide further insight. This study provides Class III evidence that in adult patients with anterior circulation LVO and low NIHSS score (≤5) presenting in the late time window (6-24 hours), EVT does not improve clinical outcome vs MM. This study was registered at clinicaltrials.gov under NCT04096248.
- Open Access
- 16 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (14) , e034948
CLEAR Thrombectomy Score: An Index to Estimate the Probability of Good Functional Outcome With or Without Endovascular Treatment in the Late Window for Anterior Circulation Occlusion
Background: With the expanding eligibility for endovascular therapy (EVT) of patients presenting in the late window (6–24 hours after last known well), we aimed to derive a score to predict favorable outcomes associated with EVT versus best medical management. Methods and Results: A multinational observational cohort of patients from the CLEAR (Computed Tomography for Late Endovascular Reperfusion) study with proximal intracranial occlusion (2014–2022) was queried (n=58 sites). Logistic regression analyses were used to derive a 9‐point score for predicting good functional outcome (modified Rankin Scale score 0–2 or return to premorbid modified Rankin Scale score) at 90 days, with sensitivity analyses for prespecified subgroups conducted using bootstrapped random forest regressions. Secondary outcomes included 90‐day functional independence (modified Rankin Scale score 0–2), poor outcome (modified Rankin Scale score 5–6), and 90‐day survival. The score was externally validated with a single‐center cohort (2014–2023). Of the 3231 included patients (n=2499 EVT), a 9‐point score included age, early computed tomography ischemic changes, and stroke severity, with higher points indicating a higher probability of a good functional outcome. The areas under the curve for the primary outcome among EVT and best medical management subgroups were 0.72 (95% CI, 0.70–0.74) and 0.87 (95% CI, 0.84–0.90), respectively, with similar performance in the external validation cohort (area under the curve, 0.71 [95% CI, 0.66–0.76]). There was a significant interaction between the score and EVT for good functional outcome, functional independence, and poor outcome (all P interaction <0.001), with greater benefit favoring patients with lower and midrange scores. Conclusions: This score is a pragmatic tool that can estimate the probability of a good outcome with EVT in the late window. Registration: URL: https://www.Clinicaltrials.gov ; Unique identifier: NCT04096248.
- 16 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (14) , e034948
Open AccessCLEAR Thrombectomy Score: An Index to Estimate the Probability of Good Functional Outcome With or Without Endovascular Treatment in the Late Window for Anterior Circulation Occlusion
Background: With the expanding eligibility for endovascular therapy (EVT) of patients presenting in the late window (6–24 hours after last known well), we aimed to derive a score to predict favorable outcomes associated with EVT versus best medical management. Methods and Results: A multinational observational cohort of patients from the CLEAR (Computed Tomography for Late Endovascular Reperfusion) study with proximal intracranial occlusion (2014–2022) was queried (n=58 sites). Logistic regression analyses were used to derive a 9‐point score for predicting good functional outcome (modified Rankin Scale score 0–2 or return to premorbid modified Rankin Scale score) at 90 days, with sensitivity analyses for prespecified subgroups conducted using bootstrapped random forest regressions. Secondary outcomes included 90‐day functional independence (modified Rankin Scale score 0–2), poor outcome (modified Rankin Scale score 5–6), and 90‐day survival. The score was externally validated with a single‐center cohort (2014–2023). Of the 3231 included patients (n=2499 EVT), a 9‐point score included age, early computed tomography ischemic changes, and stroke severity, with higher points indicating a higher probability of a good functional outcome. The areas under the curve for the primary outcome among EVT and best medical management subgroups were 0.72 (95% CI, 0.70–0.74) and 0.87 (95% CI, 0.84–0.90), respectively, with similar performance in the external validation cohort (area under the curve, 0.71 [95% CI, 0.66–0.76]). There was a significant interaction between the score and EVT for good functional outcome, functional independence, and poor outcome (all P interaction <0.001), with greater benefit favoring patients with lower and midrange scores. Conclusions: This score is a pragmatic tool that can estimate the probability of a good outcome with EVT in the late window. Registration: URL: https://www.Clinicaltrials.gov ; Unique identifier: NCT04096248.
- Open Access
- 1 July 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (7) , 1787-1797
Endovascular Versus Medical Therapy in Posterior Cerebral Artery Stroke: Role of Baseline NIHSS Score and Occlusion Site
BACKGROUND: Acute ischemic stroke with isolated posterior cerebral artery occlusion (iPCAO) lacks management evidence from randomized trials. We aimed to evaluate whether the association between endovascular treatment (EVT) and outcomes in iPCAO acute ischemic stroke is modified by initial stroke severity (baseline National Institutes of Health Stroke Scale [NIHSS]) and arterial occlusion site. METHODS: Based on the multicenter, retrospective, case-control study of consecutive iPCAO acute ischemic stroke patients (PLATO study [Posterior Cerebral Artery Occlusion Stroke]), we assessed the heterogeneity of EVT outcomes compared with medical management (MM) for iPCAO, according to baseline NIHSS score (≤6 versus >6) and occlusion site (P1 versus P2), using multivariable regression modeling with interaction terms. The primary outcome was the favorable shift of 3-month modified Rankin Scale (mRS). Secondary outcomes included excellent outcome (mRS score 0–1), functional independence (mRS score 0–2), symptomatic intracranial hemorrhage, and mortality. RESULTS: From 1344 patients assessed for eligibility, 1059 were included (median age, 74 years; 43.7% women; 41.3% had intravenous thrombolysis): 364 receiving EVT and 695 receiving MM. Baseline stroke severity did not modify the association of EVT with 3-month mRS distribution ( P interaction =0.312) but did with functional independence ( P interaction =0.010), with a similar trend on excellent outcome ( P interaction =0.069). EVT was associated with more favorable outcomes than MM in patients with baseline NIHSS score >6 (mRS score 0–1, 30.6% versus 17.7%; adjusted odds ratio [aOR], 2.01 [95% CI, 1.22–3.31]; mRS score 0 to 2, 46.1% versus 31.9%; aOR, 1.64 [95% CI, 1.08–2.51]) but not in those with NIHSS score ≤6 (mRS score 0–1, 43.8% versus 46.3%; aOR, 0.90 [95% CI, 0.49–1.64]; mRS score 0–2, 65.3% versus 74.3%; aOR, 0.55 [95% CI, 0.30–1.0]). EVT was associated with more symptomatic intracranial hemorrhage regardless of baseline NIHSS score ( P interaction =0.467), while the mortality increase was more pronounced in patients with NIHSS score ≤6 ( P interaction =0.044; NIHSS score ≤6: aOR, 7.95 [95% CI, 3.11–20.28]; NIHSS score >6: aOR, 1.98 [95% CI, 1.08–3.65]). Arterial occlusion site did not modify the association of EVT with outcomes compared with MM. CONCLUSIONS: Baseline clinical stroke severity, rather than the occlusion site, may be an important modifier of the association between EVT and outcomes in iPCAO. Only severely affected patients with iPCAO (NIHSS score >6) had more favorable disability outcomes with EVT than MM, despite increased mortality and symptomatic intracranial hemorrhage.
- 1 July 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (7) , 1787-1797
Open AccessEndovascular Versus Medical Therapy in Posterior Cerebral Artery Stroke: Role of Baseline NIHSS Score and Occlusion Site
BACKGROUND: Acute ischemic stroke with isolated posterior cerebral artery occlusion (iPCAO) lacks management evidence from randomized trials. We aimed to evaluate whether the association between endovascular treatment (EVT) and outcomes in iPCAO acute ischemic stroke is modified by initial stroke severity (baseline National Institutes of Health Stroke Scale [NIHSS]) and arterial occlusion site. METHODS: Based on the multicenter, retrospective, case-control study of consecutive iPCAO acute ischemic stroke patients (PLATO study [Posterior Cerebral Artery Occlusion Stroke]), we assessed the heterogeneity of EVT outcomes compared with medical management (MM) for iPCAO, according to baseline NIHSS score (≤6 versus >6) and occlusion site (P1 versus P2), using multivariable regression modeling with interaction terms. The primary outcome was the favorable shift of 3-month modified Rankin Scale (mRS). Secondary outcomes included excellent outcome (mRS score 0–1), functional independence (mRS score 0–2), symptomatic intracranial hemorrhage, and mortality. RESULTS: From 1344 patients assessed for eligibility, 1059 were included (median age, 74 years; 43.7% women; 41.3% had intravenous thrombolysis): 364 receiving EVT and 695 receiving MM. Baseline stroke severity did not modify the association of EVT with 3-month mRS distribution ( P interaction =0.312) but did with functional independence ( P interaction =0.010), with a similar trend on excellent outcome ( P interaction =0.069). EVT was associated with more favorable outcomes than MM in patients with baseline NIHSS score >6 (mRS score 0–1, 30.6% versus 17.7%; adjusted odds ratio [aOR], 2.01 [95% CI, 1.22–3.31]; mRS score 0 to 2, 46.1% versus 31.9%; aOR, 1.64 [95% CI, 1.08–2.51]) but not in those with NIHSS score ≤6 (mRS score 0–1, 43.8% versus 46.3%; aOR, 0.90 [95% CI, 0.49–1.64]; mRS score 0–2, 65.3% versus 74.3%; aOR, 0.55 [95% CI, 0.30–1.0]). EVT was associated with more symptomatic intracranial hemorrhage regardless of baseline NIHSS score ( P interaction =0.467), while the mortality increase was more pronounced in patients with NIHSS score ≤6 ( P interaction =0.044; NIHSS score ≤6: aOR, 7.95 [95% CI, 3.11–20.28]; NIHSS score >6: aOR, 1.98 [95% CI, 1.08–3.65]). Arterial occlusion site did not modify the association of EVT with outcomes compared with MM. CONCLUSIONS: Baseline clinical stroke severity, rather than the occlusion site, may be an important modifier of the association between EVT and outcomes in iPCAO. Only severely affected patients with iPCAO (NIHSS score >6) had more favorable disability outcomes with EVT than MM, despite increased mortality and symptomatic intracranial hemorrhage.